CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

For all the coffee lovers it's time to invest in your favourite beverage!
Shamita Nadkarni
/ Categories: Trending, Mindshare

For all the coffee lovers it's time to invest in your favourite beverage!

Tata Consumer Products Ltd on Tuesday announced that they will merge all businesses of Tata Coffee with itself.

Tata Consumer currently holds a 57.5 per cent stake in Tata Coffee. Post the merger, the extraction and branded coffee business of TCL will be a part of TCPL and the plantation business will be demerged into TCPL Food and Beverage Ltd, a wholly-owned subsidiary of TCPL. This decision is, by all means, beneficial for TCL shareholders as they (other than TCPL) will receive an aggregate of 3 equity shares of TCPL for every 10 equity shares held by them in TCL.

Tata Coffee is one of the world’s largest integrated coffee cultivations and processing companies. Its main products are Indian-origin green coffee beans, instant coffee, tea and pepper.  

The stock has rallied by 9.6 per cent since the opening bell. As of 2:55 pm, the scrip is trading at Rs 215.25.  

Previous Article Achyut Healthcare Limited and Evoq Remedies Limited become the 366th and 367th Company respectively to get listed on BSE SME Platform
Next Article India needs financial innovation to recover GDP loss from GDP growth
Print
392 Rate this article:
4.4
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR